Horizon Technology Finance and Monroe Capital Support OSSIO with a $50 Million Credit Facility for Continued Growth

FARMINGTON, Conn. & CHICAGO–(BUSINESS WIRE)–Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”), together with Monroe Capital LLC (“Monroe”), today announced the closing of an initial $40 million senior credit facility for Ossio Inc. (“OSSIO”), with an additional $10 million available to support future growth.

Founded in 2014, OSSIO is an orthopedics company committed to transforming the surgical experience for patients, physicians, providers and payors. The company’s vision is to provide the first credible replacement for metal implants in the multibillion-dollar global orthopedic fixation market with OSSIOfiber Intelligent Bone Regeneration Technology. OSSIO conducts product development and manufacturing in Caesarea, Israel, with commercial operations based in Palmetto, FL.

“We are thrilled to partner with Horizon Technology Finance and Monroe Capital on this growth capital investment. We look forward to executing on our strategy to expand our orthopedic fixation technology globally,” commented Brian Verrier, Chief Executive Officer of OSSIO. “This partnership combines deep healthcare technology expertise with growth capital. Financing from the Horizon and Monroe platform provides the resources needed to accelerate expansion while preserving the company’s mission of transforming the orthopedic experience for patients.”

“We are excited to partner with Brian and the OSSIO team as they broaden their global impact in orthopedic medical technology,” said Paul Seitz, Chief Investment Officer of Horizon. “This investment reflects Horizon’s commitment to supporting innovative, venture growth companies through strategic financing. OSSIO marks another Horizon investment within the Israeli technology ecosystem.”

“Monroe continues to see exceptional innovation emerging from the Israeli life sciences sector, and OSSIO stands out as a leading force in orthopedic and regenerative technology,” said Mark Solovy, Managing Director and Co-Head, Technology Finance Group at Monroe Capital. “Its disruptive, metal-free bone regeneration solutions align directly with our technology finance vertical, and we are proud to support Brian and his team as they globally scale OSSIO’s impact.”

About Horizon Technology Finance

Horizon Technology Finance Corporation (NASDAQ: HRZN), externally managed by Horizon Technology Finance Management LLC, an affiliate of Monroe Capital, is a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries. The investment objective of Horizon is to maximize its investment portfolio’s return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. Horizon is headquartered in Farmington, Connecticut, with a regional office in Pleasanton, California, and investment professionals located throughout the U.S. Monroe Capital is a premier asset management firm specializing in private credit markets across various strategies, including direct lending, technology finance, venture debt, opportunistic, structured credit, real estate and equity. To learn more, please visit horizontechfinance.com.

About Monroe Capital

Monroe Capital LLC (“Monroe”) is a premier asset management firm specializing in private credit markets across various strategies, including direct lending, technology finance, venture debt, alternative credit solutions, structured credit, real estate and equity. Since 2004, the firm has been successfully providing capital solutions to clients in the U.S. and Canada. Monroe prides itself on being a value-added and user-friendly partner to business owners, management, and both private equity and independent sponsors. Monroe’s platform offers a wide variety of investment products for both institutional and high net worth investors with a focus on generating high quality “alpha” returns irrespective of business or economic cycles. The firm is headquartered in Chicago and has 12 locations throughout the United States, Middle East, Asia and Australia.

Monroe has been recognized by both its peers and investors with various awards including GrowthCap Advisory’s 2025 Top Private Credit Firm List; Inc.’s 2025 Founder-Friendly Investors List; DealCatalyst as the 2025 Most Innovative Private Credit CLO Manager of the Year; Private Debt Investor as the 2024 Lower Mid-Market Lender of the Year, Americas and 2023 Lower Mid-Market Lender of the Decade; Global M&A Network as the 2024 Lower Mid-Markets Lender of the Year, Americas; Korean Economic Daily as the 2022 Best Performance in Private Debt – Mid Cap; Creditflux as the 2021 Best U.S. Direct Lending Fund; and Pension Bridge as the 2020 Private Credit Strategy of the Year. For more information and important disclaimers, please visit www.monroecap.com.

Contacts

For more information, please contact:

Investor Relations:
ICR
Garrett Edson
[email protected]
(860) 284-6450

Media Relations:
ICR
Chris Gillick
[email protected]
(646) 677-1819

Zia Uddin
Monroe Capital LLC
312-523-2374
[email protected]

Daniel Abramson
Gregory
857-305-8441
[email protected]